News & Media


Targa Biomedical at the Biotech Showcase and RESI conferences

Targa Biomedical will be attending the Biotech Showcase and RESI2023 conferences in San Francisco. January 18–19, 2023 in virtual format.


Targa Biomedical participates in the RESI conferences in Boston

Targa Biomedical takes part in the Redefining Early Stage Investments (RESI) event in hybrid format from September 21-22, 2022 in Boston and September 23, 2022 virtually.


TARGA BIOMEDICAL HAS BEEN SELECTED TO PARTICIPATE IN THE VENTURE MENTORING SERVICES PROGRAM

With support from the Canadian Trade Commissioner Service in partnership with the Maryland Tech Council (MTC), Targa Biomedical has been selected to participate in the Venture Mentoring Services Program


Targa Biomedical at BIO 2022

Targa Biomedical is attending the BIO International Convention in San Diego, CA from June 13 to 16, 2022.


Targa Biomedical selected in the top 10 list of biotech start-ups in Canada

Targa Biomedical was selected among the top 10 biotech start-ups in Canada and won the Desjardins Coup de Coeur Prize in the pan-Canadian Effervescence 2022 competition.

Click link for video


Targa Biomedical featured in Technoparc Montreal’s blog

Targa Biomedical, saving organs to save lives.

Click link for article


Targa Biomedical at the Biotech Showcase Digital

Targa Biomedical is attending the Biotech Showcase 2022, the investor and partnering conference for private, small- and mid-cap biotech companies, conferences from January 17 to 19, 2022.


Targa Biomedical has been selected to participate to the Mayo Clinic Innovation Exchange program

With financial support from the Canadian Trade Commissioner Service, Targa Biomedical has been selected to participate in the MCIE program from August 2, 2021 to February 1, 2022


Targa Biomedical at BIO Digital 2021

Targa Biomedical will be attending BIO Digital, where leaders convene from across the biotech ecosystem at the world's largest biotechnology partnering event in a re-imagined virtual setting.


Roundtable discussion: The present and future of Cell & Gene Therapy; a perspective from innovators in the Quebec ecosystem

Come join our President and CEO Shant Der Sarkissian and other leaders in the pharma and biotech industry, as well as health care sector and life science researchers, to discuss the latest developments in regenerative medicine, gene editing platforms, CRISPR therapeutics and other lessons learned during the cell therapy development journey.


Targa Biomedical is selected to join the adMare Accelerator Program for Quebec emerging companies

adMare BioInnovations, Canada’s global life sciences venture, along with contributions from the Government of Quebec through Start-Up Quebec funding from the Ministère de l’Économie et de l’Innovation, the City of Montreal, and strategic partners BIOQuébec and Montréal InVivo, supports the scale-up of promising life sciences companies through this first accelerator cohort and help them grow into new anchors for the industry.


Targa Biomedical to take part in the Global US Market Expansion Accelerator Program

The Délégation Générale du Québec in New York / Antenne du Québec in Philadelphia in collaboration with the Consulate General of Canada in New York, Investissement Québec International and The University City Science Center offer a specialized virtual accelerator program to companies in the cell and gene therapy sector in Quebec.


Targa Biomedical attends Virtual Cell and Gene on the Mesa conferences

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.


Targa Biomedical receives a SEED Showcase presentation award

Targa Biomedical is a proud recipient of a Biotech Showcase 2020 SEED Showcase presentation award.
Come join our CEO Dr Shant Der Sarkissian on Wednesday January 15 @ 4:10pm (Yocemite C, Ballroom level) to learn more about our Technology.


Targa Biomedical at the Biotech Showcase and RESI conferences

Our leadership will be attending the Biotech Showcase and RESI2020 conferences in San Francisco from January 13 to 15.


Targa Biomedical leadership will be attending BIOJapan2019

Asia's premier partnering event for the global biotechnology industry, in Yokohama Japan from October 9 to 11


Targa Biomedical at BIO 2019

Targa Biomedical will be attending the BIO International Convention, the largest biotech convention with more than 18,000 delegates from around the globe, held this year from June 3 to 6 in Philadelphia, PA.


Targa Biomedical at the JP Morgan Healthcare Conference

Our leadership, Dr Shant Der Sarkissian and Dr Nicolas Noiseux will be attending the Biotech Showcase and RESI2019 conferences in San Francisco from January 7 to 9. Come meet them and learn about Targa Biomedical’s technology in optimizing regenerative medicine and expanding organ transplantation opportunities.


Targa Biomedical is invited to present at the 2018 Innovation Forum in Life Sciences and Healthcare

Our CEO Shant Der Sarkissian will be presenting at the 2018 Innovation Forum in Life sciences and Healthcare hosted by BCF in collaboration with Deloitte and the Royal Bank of Canada.


Targa Biomedical wins the DEVTECH Life Sciences 2018 competition

Congratulations to our CEO Shant Der Sarkissian for an award-winning presentation at the DEVTECH 2018 Life Sciences competition.
Quebec international is proud to announce the three life sciences companies winning the 6th edition of the Devtech Life Sciences Competition. Set up at the level of the province of Quebec, DEVTECH is aimed at all businesses operating in the life sciences sector, whether it is in the startup, pre-commercialization or commercialization phase.


Presenting Targa Biomedical Inc. | Click link for video

Launch of Targa Biomedical

Targa Biomedical is selected as one of ten startups in the first cohort of BCF Imagine.

Click link for video